Merislon


Indications and Reactions:

Role Indications Reactions
Secondary
Dizziness 23.9%
Chronic Myeloid Leukaemia 9.0%
Hyperuricaemia 9.0%
Hypertension 8.2%
Pulmonary Hypertension 6.0%
Sudden Hearing Loss 6.0%
Hypercholesterolaemia 5.2%
Nausea 4.5%
Gastritis 3.7%
Hyperlipidaemia 3.7%
Neuropathy Peripheral 3.7%
Insomnia 3.0%
Brain Contusion 2.2%
Meniere's Disease 2.2%
Neuralgia 2.2%
Anaemia 1.5%
Constipation 1.5%
Drug Use For Unknown Indication 1.5%
Gastritis Prophylaxis 1.5%
Hypoaesthesia 1.5%
Toxic Epidermal Necrolysis 20.0%
Platelet Count Decreased 16.0%
Cardiac Arrest 8.0%
Interstitial Lung Disease 8.0%
Memory Impairment 8.0%
Tinnitus 8.0%
Altered State Of Consciousness 4.0%
Blood Pressure Decreased 4.0%
Drug Eruption 4.0%
Gastritis 4.0%
Liver Disorder 4.0%
Stomach Discomfort 4.0%
Transient Ischaemic Attack 4.0%
Urinary Incontinence 4.0%
Concomitant
Hypertension 12.3%
Dizziness 11.6%
Drug Use For Unknown Indication 10.1%
Product Used For Unknown Indication 9.1%
Prophylaxis 6.7%
Insomnia 6.3%
Rheumatoid Arthritis 6.2%
Constipation 6.0%
Osteoporosis 3.3%
Diabetes Mellitus 3.0%
Gastritis 3.0%
Hepatitis C 2.8%
Cerebral Infarction 2.7%
Pain 2.7%
Prophylaxis Against Gastrointestinal Ulcer 2.7%
Chronic Hepatitis C 2.5%
Colitis Ulcerative 2.3%
Herpes Zoster 2.3%
Gastric Ulcer 2.2%
Atrial Fibrillation 2.1%
Vomiting 13.8%
Interstitial Lung Disease 9.6%
Rhabdomyolysis 6.6%
Pulmonary Embolism 6.0%
Decreased Appetite 5.4%
Malaise 5.4%
White Blood Cell Count Decreased 5.4%
Gastric Cancer 4.8%
Intentional Drug Misuse 4.8%
Loss Of Consciousness 4.8%
Renal Disorder 4.2%
Cardiac Failure 3.6%
Cerebral Infarction 3.6%
Rash 3.6%
Somnolence 3.6%
C-reactive Protein Increased 3.0%
Hypokalaemia 3.0%
Parkinsonism 3.0%
Pneumonia 3.0%
Pyrexia 3.0%

Drug Data